ZRANB2 and cancer: Heterozygous amplifications and deletions are the main types of copy number variations in molecular VM-related DEGs in pan-cancer, among which the copy numbers of NTN1, SIPR1, LAMTOR5, and ZRANB2 are heterozygous deletions in most tumors.